Nevi
3
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by To Test The Frequency Of Braf And Nras Mutations Among Nevi
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
Research Network
Common Treatments
- To Test The Frequency Of Braf And Nras Mutations Among Nevi1
- Educational Training Program1
Active Sponsors
- Medical University of Graz1
- Northwestern University1
- Ruhr University of Bochum1
Top Investigators
Department of Dermatology, Medical University of Graz
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Northwestern University
Related Conditions
- Skin Moles1
- Cutaneous Melanoma1
- Melanoma1